[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-369737-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-369737-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","inhibition-of-colorectal-cancer-by-perillaldehyde-through-targeting-srd5a1-to-induce-autophagy-via-the-pi3kakt-pathway","Inhibition of Colorectal Cancer by Perillaldehyde Through Targeting SRD5A1 to Induce Autophagy via the PI3K/AKT Pathway","","Colorectal cancer remains difficult to treat, and the mechanisms behind perillaldehyde’s anti-CRC activity are not fully defined. This study evaluates perillaldehyde (PAH) therapeutic potential and clarifies its mechanism using CRC cell assays and a subcutaneous xenograft model. Transcriptomics highlight autophagy-related pathways and are validated with TEM, immunofluorescence, Western blotting, and inhibitor studies. SRD5A1 is identified and confirmed as a target via computational approaches, CETSA, inhibitor validation, and bioinformatics-linked clinical relevance. Results show PAH suppresses PI3K/AKT signaling, reduces SRD5A1 levels, and induces autophagy to inhibit CRC.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/inhibition-of-colorectal-cancer-by-perillaldehyde-through-targeting-srd5a1-to-induce-autophagy-via-the-pi3kakt-pathway/369737/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/inhibition-of-colorectal-cancer-by-perillaldehyde-through-targeting-srd5a1-to-induce-autophagy-via-the-pi3kakt-pathway/369737.png","ImageObject",300,407,{"name":42,"@type":43},"McQueen","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-08","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main goal of this study on perillaldehyde and colorectal cancer?","Question",{"text":63,"@type":64},"To assess the therapeutic potential of perillaldehyde against colorectal cancer and clarify the underlying mechanism of action.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which experimental approaches were used to evaluate PAH effects on colorectal cancer?",{"text":68,"@type":64},"The study used in vitro assays (CCK-8, colony formation, EdU, flow cytometry, Western blotting) and an in vivo subcutaneous xenograft mouse model, with transcriptomic analysis and autophagy validation by TEM, immunofluorescence, Western blotting, and inhibitor assays.",{"name":70,"@type":61,"acceptedAnswer":71},"How does PAH inhibit colorectal cancer according to the findings?",{"text":72,"@type":64},"PAH inhibits CRC by targeting SRD5A1, leading to autophagy induction through suppression of the PI3K/AKT pathway, supported by RNA-seq, experimental validation, and selective inhibitor results.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},369737,1790363370,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},5909890329169,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","Drug Design, Development and Therapy  \nOpen Access Full Text Article ORIGINAL RESEARCH  \nInhibition of Colorectal Cancer by Perillaldehyde Through Targeting SRD5A1 to Induce Autophagy via the PI3K/AKT Pathway  \nZhuyun Leng 1 , *, Yiqian Zhang2 , *, Mingming Guo 3 , Yan Chen4 , Zhiyong Wang2  \n1Endoscopy Center, Department of Gastroenterology, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, 200120, People’s Republic of China; 2Xiangan Hospital Xiamen University, China, School of Medicine, Xiamen University, Xiamen, 361100, People’s Republic of China; 3Naval Medical University, Shanghai, 200433, People’s Republic of China; 4Department of Pharmacy, Xiamen Susong Hospital, Xiamen, 361100, People’s Republic of China  \n*These authors contributed equally to this work  \nCorrespondence: Zhiyong Wang, Xiang’an Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, 361100, People’s Republic of China, Email [cywangzhiyong@126.com](cywangzhiyong@126.com); Yan Chen, Department of Pharmacy, Xiamen Susong Hospital, Xiamen, 361100, People’s Republic of China, [Email wzychenyan@126.com](Email wzychenyan@126.com)  \n\n| Background: Colorectal cancer (CRC) is the third most common cancer globally, with treatment challenges persisting. Perillaldehyde (PAH), a major active monomer extracted from Perilla, has shown potential against CRC, though its mechanisms remain unclear. This study aims to assess the therapeutic potential of PAH against CRC and to clarify its mechanisms of action, providing a rationale for PAH as a promising candidate for anti-CRC therapy.\u003Cbr>Methods: In vitro, we used CCK-8, colony formation, EdU assays, flow cytometry, and Western blotting to assess the effects of PAHon CRC cell proliferation and apoptosis. In vivo, a subcutaneous xenograft mouse model was established to evaluate the anti-CRC efficacy of PAH. Transcriptomic analysis was performed to identify possible mechanisms, particularly related to autophagy, and validated through TEM, immunofluorescence, Western blotting, and inhibitor assays. SRD5A1 was predicted as a potential target using Swiss Target Prediction and confirmed by molecular docking, molecular dynamics simulation, and CETSA. Bioinformatics analysis further assessed the clinical relevance and mechanism of SRD5A1, which was validated using a selective inhibitor. Results: PAH demonstrated inhibitory effects on CRC in both experimental models. RNA-seq and experimental validation suggest that PAH may inhibit CRC by modulating the PI3K/AKT pathway to induce autophagy. Bioinformatics analysis indicates that SRD5A1 could be a potential target of PAH, with PAH treatment reducing SRD5A1 levels and enhancing autophagic activity through PI3K/AKT suppression.\u003Cbr>Conclusion: PAH appears to inhibit CRC by targeting SRD5A1, thereby promoting autophagy through the PI3K/AKT pathway. This offers new perspectives for both the diagnosis and treatment of CRC.\u003Cbr>Keywords: perillaldehyde, colorectal cancer, autophagy, PI3K/AKT pathway, SRD5A1 |\n| --- |\n| Introduction\u003Cbr>CRC is one of the most common gastrointestinal malignancies. Its incidence and mortality have increased every year, taking 9.2% of the total deaths in the world annually.1 Forecasts indicate a rise in worldwide CRC cases to 2.5 million by 2035.2 Indeed, besides genetic predisposition, poor diet, smoking, obesity, and lack of physical activity in daily routine have also been established as key modifiable lifestyle factors contributing to the development of CRC.3–5 In clinical settings, therapeutic interventions for CRC basically include conventional surgery, radiotherapy, and chemotherapy,6 there is an urgent need for their alternatives, which should be more effective and safer.\u003Cbr>The PI3K/AKT signaling pathway is a major oncogenic pathway implicated in various types of cancer.7 It governs several cancer hallmarks, including cell survival, proliferation, metabolism, and metastasis. In CRC, dysregulation of the PI3K/A","cbCairfTnixbbSMY","https://ap.wps.com/l/cbCairfTnixbbSMY","pdf",9783988,14,"English","# Background\n# Methods\n# Results\n# Conclusion\n# Keywords","[{\"question\":\"What is the main goal of this study on perillaldehyde and colorectal cancer?\",\"answer\":\"To assess the therapeutic potential of perillaldehyde against colorectal cancer and clarify the underlying mechanism of action.\"},{\"question\":\"Which experimental approaches were used to evaluate PAH effects on colorectal cancer?\",\"answer\":\"The study used in vitro assays (CCK-8, colony formation, EdU, flow cytometry, Western blotting) and an in vivo subcutaneous xenograft mouse model, with transcriptomic analysis and autophagy validation by TEM, immunofluorescence, Western blotting, and inhibitor assays.\"},{\"question\":\"How does PAH inhibit colorectal cancer according to the findings?\",\"answer\":\"PAH inhibits CRC by targeting SRD5A1, leading to autophagy induction through suppression of the PI3K/AKT pathway, supported by RNA-seq, experimental validation, and selective inhibitor results.\"}]","Inhibition of Colorectal Cancer by Perillaldehyde Through Targeting SRD5A1 to Induce Autophagy via the PI3K/AKT Pathway | PDF",1790184299,35,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5d360b4e5a4bb5312da1e91a97ce679a.webp",983,1272,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d075ac975f45103c2fdd1cd2fa85d599.webp",982,1270,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8ef5b017aa496a9e6a6a1ead1c625b1d.webp",981,1269,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ab4eed0f6f4ff6d597c182397ddf82eb.webp",980,1268]